Language

Language

Vision & Mission

With the IWMF You Are Never Alone
The International Waldenstrom’s Macroglobulinemia Foundation (IWMF) is a patient-founded and patient-driven, nonprofit organization that is dedicated to a simple but compelling vision and mission.
Our Vision

A World without WM (Waldenstrom’s macroglobulinemia).

Our Mission

Support and educate everyone affected by Waldenstrom’s macroglobulinemia (WM) to improve patient outcomes while advancing the search for a cure.

Our Values
Behavior

  • Community – We believe in engaging the WM community by sharing information, providing support, and working together to eradicate the disease.
  • Teamwork – We work as a team that includes all WM stakeholders.
  • Integrity – We care about the WM community and commit to the highest financial and ethical standards, with transparency in all that we do.

Execution

  • Focus – We are fiercely dedicated to providing support and education for those affected by WM and supporting research to improve and extend lives and find a cure for the disease.
  • Collaboration – We leverage the collective passion and genius of other blood cancer organizations and the medical and research communities.
  • Accountability – We are transparent and accountable at every level to the WM community and the general public.

Global Imperatives

Research: Expand Leadership role to significantly increase the number, scope, and coordination of global WM research projects.

Patient Support:

    – Awareness: Ensure everyone affected by WM knows about the resources we offer                   

    – Education & Support: Be the authoritative source for patient and caregiver education and support

Healthcare Professionals Awareness: Reach more patients sooner by ensuring every healthcare professional working in blood cancer is aware of the IWMF and its resources.

Partnership: Actively pursue and develop relationships with like-minded organizations to accomplish our mission.

Fundraising: Significantly increase and diversify our sources of funding.